Efficacy and safety of exosomes from Wharton’s Jelly-derived mesenchymal stem cells in traumatic brain injury
MSCdE therapy is safe and effective in improving motor function, cognition, and quality of life in TBI patients. Larger, controlled trials are needed to further validate these findings and optimize MSCdE therapy for TBI treatment.
Authors
- Serdar Kabataş (ORCID: https://orcid.org/0000-0003-2691-6861)
- Mehmet Abdussamet Bozkurt (ORCID: https://orcid.org/0000-0003-3222-9363)
- Necati Kaplan (ORCID: https://orcid.org/0000-0001-5672-0566)
- Tunç Akkoç (ORCID: https://orcid.org/0000-0001-9179-2805)
- Eyüp Can Savrunlu
- Erdal Karaöz
- Erdinç Civelek
- Nurten Küçükçakır
Institutions
- Bursa Technical University (TR)
- Aesthetic Surgery Center (US)
- Istinye University (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Gaziosmanpaşa Taksim Eğitim ve Araştırma Hastanesi (TR)
- Liv Hospital (TR)
- S.B.Ü. Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi (TR)
- Marmara University (TR)
- University of Health Sciences Antigua (AG)
Publication Details
- Journal
- World Journal of Critical Care Medicine
- Published
- 2025-11-28
- DOI
- https://doi.org/10.5492/wjccm.v14.i4.103782
- Citations
- 2
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 1.61